The MKKS gene helps make a protein that supports cilia, the tiny structures cells use to guide early body development. If this gene does not work properly, it can lead to changes present from birth, such as extra fingers or toes, heart differences, or changes in the genitals or urinary tract. This gene plays an important role in how the body forms during pregnancy, and some people with MKKS variants have McKusick-Kaufman syndrome or a form of Bardet-Biedl syndrome.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do much of the work inside cells. Others mainly direct when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
MKKSGene function
What if the gene works
The MKKS gene helps cells build and maintain cilia, the tiny hairlike structures that act like sensors. This supports signaling during early development and in tissues such as the eyes, heart, and reproductive organs.
Risk
What if the gene does not work
Variants in the MKKS gene can cause McKusick-Kaufman syndrome, with extra fingers or toes, genital differences, and heart differences, or Bardet-Biedl syndrome type 6, which may affect vision, weight, and kidneys. Mild and severe variants can alter features and severity.
Treatment
What does that mean for your treatment
No MKKS-specific treatment or drug-choice approach is currently established for people with a pathogenic or loss-of-function variant in the MKKS gene. Treatment is guided by the person’s symptoms and organ involvement, not by a gene-directed medicine. The MKKS gene is being studied in ciliopathy research, but this has not yet led to a guideline-based therapy.
Conditions associated with MKKS
Gene function
What if the gene works
Many cells use the MKKS gene to build and support cilia, tiny antenna-like structures on the cell surface. These structures help cells sense signals and move key materials in an orderly way. Understanding what the MKKS gene does in the body helps explain how tissues coordinate growth and daily cell activity.
The MKKS gene helps cells build cilia, which are tiny projections that act like sensors. This matters in organs such as the eyes, kidneys, and reproductive tract, where cells rely on cilia to detect signals and keep traffic moving.
Its protein helps other cilia-related proteins fold into the right shape and come together as a working group. This assembly step supports the BBSome, a protein team that helps cilia carry materials to the right place.
The MKKS protein works near the base of the cilium, where cells sort which proteins can enter or leave. This helps keep the cilium organized so it can do its sensing job day to day.
By supporting healthy cilia, the MKKS gene helps cells receive and pass along chemical messages from their surroundings. These messages guide routine processes such as growth, how tissues take shape, and timing during development.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MKKS gene can change the shape or stability of the MKKS protein, so it may fold poorly, break down early, or interact less well with partner proteins needed for cilia, the cell’s tiny sensing structures. In plain terms, this is how MKKS gene variants affect protein function. Milder variants may leave some activity, while more severe loss-of-function variants can remove most or all activity. That difference can influence how early MKKS-related features appear and how broad they are.
How variants are linked to conditions
Pathogenic variants in both copies of the MKKS gene cause McKusick-Kaufman syndrome, which is linked to extra fingers or toes, heart differences, and a fluid buildup in the vagina and uterus in some newborn girls. Some variants in the MKKS gene are also associated with Bardet-Biedl syndrome, which can affect vision, weight, kidney health, and learning over time. Because these conditions can look similar early in life, the MKKS gene may be linked to different diagnoses in different families.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the MKKS gene. In families with a disease-causing MKKS variant, risk is mainly shaped by the variant itself and whether a child inherits it from both parents.
Inheritance of MKKS variants
MKKS-related conditions are usually inherited in an autosomal recessive pattern. In practical terms, how MKKS gene variants are inherited most often means a child receives one altered copy of the MKKS gene from each parent. Parents who each carry one variant are usually unaffected, and with each pregnancy there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy.
What does my MKKS result mean for my family?
For MKKS, family implications are usually the same across the well-known conditions linked to this gene: they tend to run in families in a recessive way. This means parents are often healthy carriers, and brothers or sisters may also be carriers or, less often, may have the condition. Close relatives may want to learn whether the same MKKS change is present in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the MKKS gene, clinicians use genetic testing for MKKS variants on a blood or saliva sample. A lab reads the gene's DNA code and may also check for missing or extra pieces. Results can show a disease-causing variant, a benign variant, or a variant of uncertain significance, which needs careful interpretation.
When should I consider getting a genetic test?
Consider MKKS testing if a child has signs of McKusick-Kaufman syndrome or Bardet-Biedl syndrome, such as extra fingers or toes, heart or genital differences, early vision loss, or kidney problems. It can also help when these conditions run in the family or when both parents are known carriers.
A genetic result is only one part of your health story
Genetic test results can provide meaningful information, but how much they reveal depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body works. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a medication faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, cause more side effects in another, or seem to have less effect in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. It studies links between genes and medications to help explain why the same treatment can work differently from one person to another. For many drugs, genes influence both how strongly a medicine works and how the body handles it. This information can support more informed, personalized treatment decisions. To explore this topic further, you can find more in the LearnHub.
Drugs influenced by the MKKS gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so medication questions are best discussed with your doctor or pharmacist. Seek medical advice if you have side effects, your treatment is not working as expected, or you are worried about how your health condition may affect medicine choices.
History
MKKS entered medical genetics through families described with what is now called McKusick-Kaufman syndrome, a condition first recognized in Amish communities in the 1970s. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped connect careful clinical observation with modern genetic testing. In the late 1990s, researchers identified the MKKS gene and linked it to these inherited features. Building on this early work, scientists also found that some variants in the MKKS gene could overlap with Bardet-Biedl syndrome, which sharpened how these conditions were classified. Over time, descriptions became more precise, and the gene’s place in inherited developmental conditions became clearer.